388 related articles for article (PubMed ID: 32711865)
21. Resonance Raman measurement of macular carotenoids in normal subjects and in age-related macular degeneration patients.
Bernstein PS; Zhao DY; Wintch SW; Ermakov IV; McClane RW; Gellermann W
Ophthalmology; 2002 Oct; 109(10):1780-7. PubMed ID: 12359594
[TBL] [Abstract][Full Text] [Related]
22. Putative protective role of lutein and zeaxanthin in diabetic retinopathy.
Neelam K; Goenadi CJ; Lun K; Yip CC; Au Eong KG
Br J Ophthalmol; 2017 May; 101(5):551-558. PubMed ID: 28232380
[TBL] [Abstract][Full Text] [Related]
23. Effect of Omega-3 Fatty Acids, Lutein/Zeaxanthin, or Other Nutrient Supplementation on Cognitive Function: The AREDS2 Randomized Clinical Trial.
Chew EY; Clemons TE; Agrón E; Launer LJ; Grodstein F; Bernstein PS;
JAMA; 2015 Aug; 314(8):791-801. PubMed ID: 26305649
[TBL] [Abstract][Full Text] [Related]
24. Effect of long-chain ω-3 fatty acids and lutein + zeaxanthin supplements on cardiovascular outcomes: results of the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.
; Bonds DE; Harrington M; Worrall BB; Bertoni AG; Eaton CB; Hsia J; Robinson J; Clemons TE; Fine LJ; Chew EY
JAMA Intern Med; 2014 May; 174(5):763-71. PubMed ID: 24638908
[TBL] [Abstract][Full Text] [Related]
25. Macular xanthophylls and ω-3 long-chain polyunsaturated fatty acids in age-related macular degeneration: a randomized trial.
Arnold C; Winter L; Fröhlich K; Jentsch S; Dawczynski J; Jahreis G; Böhm V
JAMA Ophthalmol; 2013 May; 131(5):564-72. PubMed ID: 23519529
[TBL] [Abstract][Full Text] [Related]
26. Oral supplementation of lutein/zeaxanthin and omega-3 long chain polyunsaturated fatty acids in persons aged 60 years or older, with or without AMD.
Huang LL; Coleman HR; Kim J; de Monasterio F; Wong WT; Schleicher RL; Ferris FL; Chew EY
Invest Ophthalmol Vis Sci; 2008 Sep; 49(9):3864-9. PubMed ID: 18450596
[TBL] [Abstract][Full Text] [Related]
27. The role of omega-3 and micronutrients in age-related macular degeneration.
Querques G; Souied EH
Surv Ophthalmol; 2014; 59(5):532-9. PubMed ID: 24657038
[TBL] [Abstract][Full Text] [Related]
28. Prevention and treatment of age-related macular degeneration: an update for pharmacists.
Marshall LL; Roach JM
Consult Pharm; 2013 Nov; 28(11):723-37. PubMed ID: 24217192
[TBL] [Abstract][Full Text] [Related]
29. Combination of Lutein and Zeaxanthin, and DHA Regulated Polyunsaturated Fatty Acid Oxidation in H
Leung HH; Galano JM; Crauste C; Durand T; Lee JC
Neurochem Res; 2020 May; 45(5):1007-1019. PubMed ID: 32088804
[TBL] [Abstract][Full Text] [Related]
30. [Nutrition and age-related macular degeneration].
Desmettre T; Lecerf JM; Souied EH
J Fr Ophtalmol; 2004 Nov; 27(9 Pt 2):3S38-56. PubMed ID: 15602406
[TBL] [Abstract][Full Text] [Related]
31. Lutein and Zeaxanthin-Food Sources, Bioavailability and Dietary Variety in Age-Related Macular Degeneration Protection.
Eisenhauer B; Natoli S; Liew G; Flood VM
Nutrients; 2017 Feb; 9(2):. PubMed ID: 28208784
[TBL] [Abstract][Full Text] [Related]
32. Associations between intermediate age-related macular degeneration and lutein and zeaxanthin in the Carotenoids in Age-related Eye Disease Study (CAREDS): ancillary study of the Women's Health Initiative.
Moeller SM; Parekh N; Tinker L; Ritenbaugh C; Blodi B; Wallace RB; Mares JA;
Arch Ophthalmol; 2006 Aug; 124(8):1151-62. PubMed ID: 16908818
[TBL] [Abstract][Full Text] [Related]
33. Dietary lutein, zeaxanthin, and fats and the progression of age-related macular degeneration.
Robman L; Vu H; Hodge A; Tikellis G; Dimitrov P; McCarty C; Guymer R
Can J Ophthalmol; 2007 Oct; 42(5):720-6. PubMed ID: 17724493
[TBL] [Abstract][Full Text] [Related]
34. Age-related macular degeneration and antioxidant vitamins: recent findings.
Johnson EJ
Curr Opin Clin Nutr Metab Care; 2010 Jan; 13(1):28-33. PubMed ID: 19841580
[TBL] [Abstract][Full Text] [Related]
35. Lutein and Zeaxanthin Isomers in Eye Health and Disease.
Mares J
Annu Rev Nutr; 2016 Jul; 36():571-602. PubMed ID: 27431371
[TBL] [Abstract][Full Text] [Related]
36. Lutein and zeaxanthin protect photoreceptors from apoptosis induced by oxidative stress: relation with docosahexaenoic acid.
Chucair AJ; Rotstein NP; Sangiovanni JP; During A; Chew EY; Politi LE
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5168-77. PubMed ID: 17962470
[TBL] [Abstract][Full Text] [Related]
37. Effect of lutein and zeaxanthin on macular pigment and visual function in patients with early age-related macular degeneration.
Ma L; Yan SF; Huang YM; Lu XR; Qian F; Pang HL; Xu XR; Zou ZY; Dong PC; Xiao X; Wang X; Sun TT; Dou HL; Lin XM
Ophthalmology; 2012 Nov; 119(11):2290-7. PubMed ID: 22858124
[TBL] [Abstract][Full Text] [Related]
38. Lutein and zeaxanthin dietary supplements raise macular pigment density and serum concentrations of these carotenoids in humans.
Bone RA; Landrum JT; Guerra LH; Ruiz CA
J Nutr; 2003 Apr; 133(4):992-8. PubMed ID: 12672909
[TBL] [Abstract][Full Text] [Related]
39. Nonneovascular Age-Related Macular Degeneration.
Michels S; Garhöfer G
Dev Ophthalmol; 2016; 55():112-24. PubMed ID: 26502209
[TBL] [Abstract][Full Text] [Related]
40. Intakes of Lutein, Zeaxanthin, and Other Carotenoids and Age-Related Macular Degeneration During 2 Decades of Prospective Follow-up.
Wu J; Cho E; Willett WC; Sastry SM; Schaumberg DA
JAMA Ophthalmol; 2015 Dec; 133(12):1415-24. PubMed ID: 26447482
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
